Isoflurane exerts neuroprotective actions at or near the time of severe traumatic brain injury.
Isoflurane improves outcome vs. fentanyl anesthesia, in experimental traumatic brain injury (TBI). We assessed the temporal profile of isoflurane neuroprotection and tested whether isoflurane confers benefit at the time of TBI. Adult, male rats were randomized to isoflurane (1%) or fentanyl (10 mcg/kg iv bolus then 50 mcg/kg/h) for 30 min pre-TBI. Anesthesia was discontinued, rats recovered to tail pinch, and TBI was delivered by controlled cortical impact. Immediately post-TBI, rats were randomized to 1 h of isoflurane, fentanyl, or no additional anesthesia, creating 6 anesthetic groups (isoflurane:isoflurane, isoflurane:fentanyl, isoflurane:none, fentanyl:isoflurane, fentanyl:fentanyl, fentanyl:none). Beam balance, beam walking, and Morris water maze (MWM) performances were assessed over post-trauma d1-20. Contusion volume and hippocampal survival were assessed on d21. Rats receiving isoflurane pre- and post-TBI exhibited better beam walking and MWM performances than rats treated with fentanyl pre- and any treatment post-TBI. All rats pretreated with isoflurane had better CA3 neuronal survival than rats receiving fentanyl pre- and post-TBI. In rats pretreated with fentanyl, post-traumatic isoflurane failed to affect function but improved CA3 neuronal survival vs. rats given fentanyl pre- and post-TBI. Post-traumatic isoflurane did not alter histopathological outcomes in rats pretreated with isoflurane. Rats receiving fentanyl pre- and post-TBI had the worst CA1 neuronal survival of all groups. Our data support isoflurane neuroprotection, even when used at the lowest feasible level before TBI (i.e., when discontinued with recovery to tail pinch immediately before injury). Investigators using isoflurane must consider its beneficial effects in the design and interpretation of experimental TBI research.
Statler
Kimberly D
KD
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. kim.statler@hsc.utah.edu
Alexander
Henry
H
Vagni
Vincent
V
Holubkov
Richard
R
Dixon
C Edward
CE
Clark
Robert S B
RS
Jenkins
Larry
L
Kochanek
Patrick M
PM
D018686:Anesthetics, Intravenous / Q000008:administration & dosage; D000818:Animals; D001522:Behavior, Animal; D001794:Blood Pressure / Q000187:drug effects; D001930:Brain Injuries / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D002452:Cell Count / Q000379:methods; D004195:Disease Models, Animal; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005283:Fentanyl / Q000008:administration & dosage; D007530:Isoflurane / Q000008:administration & dosage*; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D018696:Neuroprotective Agents / Q000008:administration & dosage*; D011597:Psychomotor Performance / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D013997:Time Factors
D018686:Anesthetics, Intravenous; D018696:Neuroprotective Agents; D007530:Isoflurane; D005283:Fentanyl